Internal Medicine, Hematology & Oncology · Ponce, PR
NPI
1588622674
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
Edificio Porrata Pila 2431 Ave Las Americas, Suite 105
Ponce, PR, 00717
Phone (787) 841-0587
Medicare paid, 2024
$13K
468 services
Medicare patients, 2024
12
Average age 81
Drug cost, 2024
$4.0M
1,018 prescriptions
Company payments, 2025
$320
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto Velazquez Torres was code 99213 (office e&m - established), 33 times for 12 patients. In total Roberto Velazquez Torres billed 468 services in 15 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 33 | 12 | $39.29 | $1,297 |
By year: 2022 $216K for 7,184 services; 2023 $237K for 5,999 services; 2024 $13K for 468 services.
Medicare prescription drug claims, 2024
In 2024, the drug Roberto Velazquez Torres prescribed most often to Medicare patients was Anastrozole, with 124 prescriptions and refills. In total Roberto Velazquez Torres wrote 1,018 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 124 | 150 | 26 | $1,988 |
| Imatinib Mesylate Generic | 108 | 108 | Under 11 | $134K |
| Hydroxyurea Generic | 81 | 93 | 12 | $2,488 |
| Imbruvica Ibrutinib | 79 | 79 | Under 11 | $1.3M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 38 | 38 | 22 | $860 |
| Exemestane Generic | 36 | 46 | Under 11 | $3,023 |
| Prednisone Generic | 29 | 33 | 13 | $226 |
| Revlimid Lenalidomide | 28 | 28 | Under 11 | $517K |
| Dexamethasone Generic | 28 | 28 | 17 | $796 |
| Tramadol Hcl Generic | 26 | 26 | Under 11 | $182 |
| Spironolactone Generic | 21 | 21 | 13 | $294 |
| Keytruda Pembrolizumab | 20 | 20 | Under 11 | $227K |
| Everolimus Generic | 13 | 13 | Under 11 | $17K |
| Opdivo Nivolumab | 13 | 13 | Under 11 | $196K |
| Ciprofloxacin Hcl Generic | 13 | 13 | Under 11 | $120 |
Brand drugs: 303 claims; generic drugs: 715 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto Velazquez Torres $320 ($320 in general payments such as food, travel and fees) from 10 companies. The largest payer was Pbg Puerto Rico LLC with $127.
| Company | Payments | Amount |
|---|---|---|
| Pbg Puerto Rico LLC | 6 | $127 |
| Medtronic, Inc. MDT | 1 | $33.34 |
| GlaxoSmithKline, LLC. GSK | 1 | $25 |
| Adc Therapeutics America, Inc. | 1 | $21.4 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $21.4 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $20.33 |
| Merck Sharp & Dohme LLC MRK | 1 | $19.86 |
| Gilead Sciences, Inc. GILD | 1 | $19.77 |
| Abbvie Inc. ABBV | 1 | $19.44 |
| pharmaand GmbH | 1 | $12.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.